Vascular Sealant Market Study Explores Industry Growth Toward $2.51 Billion

The vascular sealant market is on the cusp of notable expansion, driven by advancements in medical technology and changing surgical practices. As healthcare systems increasingly adopt innovative solutions to improve patient outcomes, this sector is set to witness significant growth and transformation. Let's explore the market's anticipated size, key players, emerging trends, and main segments shaping its future trajectory.

Projected Market Size and Growth Trends in the Vascular Sealant Market
The vascular sealant market is forecasted to grow substantially, reaching a valuation of $2.51 billion by 2030. This represents a compound annual growth rate (CAGR) of 8.0% during the forecast period. Several factors contribute to this rise, including the growing preference for minimally invasive surgeries, the demand for advanced biomaterials, increased investments in surgical innovations, the expansion of outpatient surgical centers, and a stronger focus on patient safety and quicker recovery times. Important market trends to watch include the rising use of sophisticated hemostatic agents in surgical procedures, a growing inclination toward minimally invasive sealants, demand for sealants that act quickly and offer high strength, the development of bioresorbable and biocompatible materials, and the broadening application of multi-purpose sealants across various surgical fields.

Download a free sample of the vascular sealant market report:
https://www.thebusinessresearchcompany.com/sample_request?id=38364006&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jun_PR

Leading Organizations Influencing the Vascular Sealant Market
The vascular sealant industry features several prominent companies shaping its landscape. Key players include Johnson & Johnson, Pfizer Inc., Medtronic plc, Stryker Corporation, Becton dic*kinson and Company, Baxter International Inc., B. Braun Melsungen AG, Grifols S. A., Terumo Corporation, Teleflex Incorporated, Integra LifeSciences Holdings Corporation, CSL Behring LLC, Advanced Medical Solutions Group plc, SkinStitch Inc., Tricol Biomedical Inc., Cellphire Therapeutics Inc., Artivion Inc., GluStitch Inc., CuraMedical B. V., and Endomedix Inc.
In January 2026, Haemonetics Corporation, a US-based medical technology firm, acquired Ireland's Vivasure Medical Limited for an undisclosed sum. This acquisition aims to enhance Haemonetics' portfolio of large-bore vascular closure devices, strengthen its capabilities in minimally invasive vascular procedures, accelerate innovation in structural heart and endovascular treatments, and expand its global reach in interventional cardiology and vascular surgery. Vivasure Medical Limited specializes in developing vascular sealant technologies.

Technological Advances Driving Innovation in the Vascular Sealant Market
Companies in this market are focusing on pioneering technologies such as grip technology to speed up hemostasis and improve patient recovery experiences. Grip technology utilizes a hydrophilic polymer-based system that creates a secure, flexible seal at vascular access points. This innovation helps achieve rapid hemostasis, reduces bleeding risks, shortens recovery time, and allows patients to walk sooner and be discharged earlier. It also provides a minimally invasive alternative to traditional manual compression.
For example, in July 2024, Cordis Corporation, a US medical device company, received FDA approval for its Mynx Control Venous VCD, which employs grip technology based on hydrophilic, bioinert polyethylene glycol. This device is designed for effective closure of midbore venous puncture sites, including those used in electrophysiology procedures. Clinical trials demonstrated a 100% success rate in both procedural and device outcomes. Benefits include a significant reduction in time to hemostasis (2.1 minutes versus 11.4 minutes with manual compression), faster patient ambulation, and earlier eligibility for discharge, all contributing to enhanced patient care and operational efficiency.

View the full vascular sealant market report:
https://www.thebusinessresearchcompany.com/report/vascular-sealant-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jun_PR

Key Segments Defining the Vascular Sealant Market Structure
The vascular sealant market is divided into several important segments to better understand its scope:
1) Product Type: Fibrin Sealants, Collagen Based Sealants, Synthetic Sealants, and Other Product Types
2) Material Type: Natural Biological Materials, Synthetic Polymeric Materials, and Semi Synthetic Materials
3) Form Factor: Liquid, Patch, Spray or Foam, and Pre-Filled Applicator Kits
4) Application Areas: Cardiovascular Surgery, General Surgery, Neurosurgery, Orthopedic Surgery, and Other Applications
5) End User Categories: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Other End Users

Further breakdowns include:
- Fibrin Sealants: Human Plasma Derived, Bovine Plasma Derived, Recombinant, and Combination Fibrin Sealants
- Collagen Based Sealants: Bovine, Porcine, Equine, and Crosslinked Collagen Sealants
- Synthetic Sealants: Polyethylene Glycol, Cyanoacrylate, Albumin Based, and Gelatin Based Sealants
- Other Product Types: Combination Sealants, Hydrogel Sealants, Polysaccharide Based Sealants, and Enzymatic Sealants

This comprehensive segmentation helps provide a detailed view of the vascular sealant market's diversity and the wide range of options available to healthcare providers.

Our 2026 market reports now include enhanced strategic insights through:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.